Advanced BioMedical Technologies Inc
(OTCPK:ABMT)
$0.0579
0.0159[37.89%]
Last update: 8:07AM (Delayed 15-Minutes)
Get Real Time Here
$0.0579
0[0.00%]
Open-Close-
Vol / Avg.0 / 3.272KMkt Cap4.066M
Day Range- - -52 Wk Range0.030 - 0.059

Advanced BioMedical Techs Stock (OTC:ABMT), Key Statistics

Advanced BioMedical Techs Stock (OTC: ABMT) analysis, key statistics.

Valuation Measures
Enterprise Value
2.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
8.6M
Total Assets
396.5K
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
78.89%
Net Margin
-110396.11%
EBIT Margin
-64975%
EBITDA Margin
-61320%
Operating Margin
-62095.56%

Advanced BioMedical Techs Stock (OTC:ABMT), Key Statistics

Advanced BioMedical Techs Stock (OTC: ABMT) analysis, key statistics.

Valuation Measures
Enterprise Value
2.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
8.6M
Total Assets
396.5K
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
78.89%
Net Margin
-110396.11%
EBIT Margin
-64975%
EBITDA Margin
-61320%
Operating Margin
-62095.56%

Advanced BioMedical Techs Stock (OTC:ABMT), Key Statistics

Advanced BioMedical Techs Stock (OTC: ABMT) analysis, key statistics.

Valuation Measures
Enterprise Value
2.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
8.6M
Total Assets
396.5K
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
78.89%
Net Margin
-110396.11%
EBIT Margin
-64975%
EBITDA Margin
-61320%
Operating Margin
-62095.56%

Advanced BioMedical Techs Stock (OTC:ABMT), Key Statistics

Advanced BioMedical Techs Stock (OTC: ABMT) analysis, key statistics.

Valuation Measures
Enterprise Value
2.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
8.6M
Total Assets
396.5K
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
78.89%
Net Margin
-110396.11%
EBIT Margin
-64975%
EBITDA Margin
-61320%
Operating Margin
-62095.56%

Advanced BioMedical Techs Stock (OTC:ABMT), Key Statistics

Advanced BioMedical Techs Stock (OTC: ABMT) analysis, key statistics.

Valuation Measures
Enterprise Value
2.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
8.6M
Total Assets
396.5K
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
78.89%
Net Margin
-110396.11%
EBIT Margin
-64975%
EBITDA Margin
-61320%
Operating Margin
-62095.56%

Advanced BioMedical Techs Stock (OTC:ABMT), Key Statistics

Advanced BioMedical Techs Stock (OTC: ABMT) analysis, key statistics.

Valuation Measures
Enterprise Value
2.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
8.6M
Total Assets
396.5K
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
78.89%
Net Margin
-110396.11%
EBIT Margin
-64975%
EBITDA Margin
-61320%
Operating Margin
-62095.56%

Advanced BioMedical Techs Stock (OTC:ABMT), Key Statistics

Advanced BioMedical Techs Stock (OTC: ABMT) analysis, key statistics.

Valuation Measures
Enterprise Value
2.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
8.6M
Total Assets
396.5K
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
78.89%
Net Margin
-110396.11%
EBIT Margin
-64975%
EBITDA Margin
-61320%
Operating Margin
-62095.56%

Advanced BioMedical Techs Stock (OTC:ABMT), Key Statistics

Advanced BioMedical Techs Stock (OTC: ABMT) analysis, key statistics.

Valuation Measures
Enterprise Value
2.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
8.6M
Total Assets
396.5K
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
78.89%
Net Margin
-110396.11%
EBIT Margin
-64975%
EBITDA Margin
-61320%
Operating Margin
-62095.56%

Advanced BioMedical Techs Stock (OTC:ABMT), Key Statistics

Advanced BioMedical Techs Stock (OTC: ABMT) analysis, key statistics.

Valuation Measures
Enterprise Value
2.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
8.6M
Total Assets
396.5K
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
78.89%
Net Margin
-110396.11%
EBIT Margin
-64975%
EBITDA Margin
-61320%
Operating Margin
-62095.56%